asacol mesalazine 1.6 g enteric coated tablet blister pack
chiesi australia pty ltd - mesalazine, quantity: 1.6 g - tablet, enteric coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; hypromellose; colloidal anhydrous silica; magnesium stearate; macrogol 6000; methacrylic acid copolymer; triethyl citrate; glyceryl monostearate; polysorbate 80; sodium hydroxide; maize starch; iron oxide red; iron oxide yellow; monobasic potassium phosphate - asacol is indicated for the treatment of mild to moderate ulcerative colitis and maintenance of remission in adults.
mezavant xl 1200 mg gastro-resistant, prolonged release tablets
takeda pharmaceuticals international ag ireland branch - mesalazine - prolonged-release tablet - 1200 milligram(s) - aminosalicylic acid and similar agents; mesalazine
pentasa
pharmaco (nz) ltd - mesalazine 1 g; ; mesalazine 1 g - modified release granules - 1 g - active: mesalazine 1 g excipient: acetone ethylcellulose microcrystalline cellulose purified water active: mesalazine 1 g excipient: acetone ethylcellulose povidone purified water - treatment of mild to moderate ulcerative colitis
pentasa mesalazine 1g/100ml enema
ferring pharmaceuticals ltd - mesalazine - enema - 10mg/1ml
salofalk 1g suppositories
dr. falk pharma uk ltd - mesalazine - suppository - 1gram
salofalk enemas
dch auriga (malaysia) sdn. bhd. - 5-amino salicylic acid(5-asa),mesalazine -
pentasa 1g suppositories
ferring ireland ltd - mesalazine - suppository - 1 gram(s) - aminosalicylic acid and similar agents; mesalazine
pentasa 10 mg/ml rectal suspension
ferring ireland ltd - mesalazine - rectal suspension - 10 milligram(s)/millilitre - aminosalicylic acid and similar agents; mesalazine
salofalk
dr. falk pharma gmbh leinenweberstr 579108 freiburg, germany - mesalazine - tablet - mesalazine 500 mg - antidiarrheals, intestinal antiinflammatory/antiinfective agents
pentasa slow release tablets 1 gram
ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 1 g - mesalazine - mild to moderate ulcerative colitis. crohn's disease.